Journals / Dicle Tıp Dergisi / 2005 / Cilt: 32 - Sayı: 2

Bone mineral metabolism in chronic liver diseases

Kronik karaciğer hastalıklarında kemik mineral metabolizması

Pages
57–62
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a conclusion of this study; in pediatric age group of chronic liver patients, bone mineralization changing start even before cirrhosis is developed and this changing were detected as increase of osteoclastic activity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Fifty-five patients with chronic liver disease and fifty-eight control group patients who ages change 5 between 16 were analyzed for evaluation of bone mineral metabolism marker in the department of pediatric gastroenterology.
📊
Key Findings & Data:There was no statistical significance amongparameters of age, urine calcium, urine creatinin, urine protein, urine calcium/creatinin rate, serum calcium, osteocalsin and alkaline phosphatase levels (p>0.05).
💡
Conclusion & Impact:As a conclusion of this study; in pediatric age group of chronic liver patients, bone mineralization changing start even before cirrhosis is developed and this changing were detected as increase of osteoclastic activity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Çocuk · Ergen · Çocuk

Abstract

Fifty-five patients with chronic liver disease and fifty-eight control group patients who ages change 5 between 16 were analyzed for evaluation of bone mineral metabolism marker in the department of pediatric gastroenterology. There was no statistical significance amongparameters of age, urine calcium, urine creatinin, urine protein, urine calcium/creatinin rate, serum calcium, osteocalsin and alkaline phosphatase levels (p>0.05). There was statistically significant result between parathyroid hormone and p-crosslaps levels between patients group and control group (p<0.05). P-crosslaps and urine calcium result showed very low positive correlation (r=0.289, p=0.44); also weak positive correlation between phosphatase levels and urine calcium were (r=0.353, p=0.010), and between osteocalsin and fi-crosslaps with weak positive correlation (r =0.393, p=0.005). As a conclusion of this study; in pediatric age group of chronic liver patients, bone mineralization changing start even before cirrhosis is developed and this changing were detected as increase of osteoclastic activity.

Özet

Çocuk Gastroenteroloji polikliniğinde; kronik viral hepatit tanısı ile izlenen yaşları 5-16 arasında değişen 55 kronik karaciğer hastası ve benzer yaşlarda herhangi bir kronik hastalığı bulunmayan 58 vakadan oluşan sağlıklı kontrol grubunun kemik mineral metabolizma belirteçlerinin karşılaştırılması amaçlandı. Karşılaştırma yapılan parametreler olan; yaş, idrar kalsiyum, idrar kreatinin, idrar protein, idrar kalsiyum/kreatinin oranı, serum kalsiyum, osteokalsin ve alkalen fosfataz değerlerinde hasta ve kontrol grubu arasında istatistiksel olarak anlamlı farklılık bulunmazken (p>0.05); Paratiroid hormon ve p-crosslaps arasındaki fark ise istatistiksel olarak anlamlı bulundu (p<0.05). p-crosslaps ile idrar kalsiyumu arasında zayıf pozitif korelasyon (r -0.289, p=0.44); Alkalen fosfataz ile idrar kalsiyumu arasında da zayıf pozitif korelasyon (r =0.353, p=0.010) saptandı. Osteokalsin ile P-crosslaps arasında da zayıf pozitif korelasyon (r =0.393, p =0.005) tespit edildi. Sonuç olarak, çocuk yaş grubundaki kronik karaciğer hastalarında (HBV, HCV veya HDV'nin neden olduğu karaciğer hastalıklarının), siroz gelişmeden dahi kemik mineralizasyon değişikliklerinin başladığı ve bu değişikliklerin osteoklastik aktivitenin artması yönünde olduğu saptandı. Bu grup hastalarda osteoklastik aktivitenin ilk belirteçlerinden biri de P-crosslaps idi.

🔖

Cite This Article

ECER, S., DİKİCİ, B., HASPOLAT, K. (2005). Bone mineral metabolism in chronic liver diseases. Dicle Tıp Dergisi, Cilt: 32 - Sayı: 2, 57–62. https://ajindex.com/articles/349174

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Dequeker J, Ranstam J, Valsson J, et al. The Mediteranean Osteoporosis Study (MEDOS) Questionnaire. Clin Rheumatol 1991;10:54-72
  2. Switzer BR. Determination of hydroxyproline in tissue. J Nutr Biochem. 1991;2:229-31
  3. Sheila Sherlock, James Dooley. Dieseases of the liver and biliary system: 228
  4. Karan MA, Erten N, Tascioğlu C, et al. Osyeodistrophy in Posthepatitic Cirrhosis. Yonsei Medical Journal 2001;42:547-52
  5. Tsuneoka K, Tameda Y, Takase K, et al. Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol. 1996;31:669-78 6. Chen CC, Wang SS. Metabolic bone disease of liver cirrhosis is a parallel to the clinical severity of cirrhosis. J Gastroenterol Hepatol. 1996; 11:417-21
  6. Suzuki K, Arakawa Y, Chino S, et al. Hepatic osteodystrophy. Nippon Rinsho. 1998;56:1604-8
  7. Diamond TH, Stiel D. Hepatic osteodystrophy. Gastroenterology. 1989;96:213-21
  8. Resch H, Pietschmann P, Krexner E, et al. Peripheral bone mineral content in patients with fatty liver and hepatic cirrhosis. Scand J Gastroenterol 1990;25:412-6
  9. Capra F, Casaril M, Gabrielli GB, et al. Plasma osteocalcin levels in liver cirrhosis. İtal J Gastroenterol 1991:23;124-7
  10. Doherty GM, Wells SA. Parathyroid glans. In Surgery. Greenfield LJ (ed). Second ed. Lippincott-Raven. Philadelphia. Pp:1308 12. Louboutin JY, Feullu A. Hyperparathyroidism secondary to cirrhosis. Rev Rhum Mal Osteoartic. 1980;47:707
  11. Kirch W, Hofig M. Parathyroid hormone and cirrhosis of the liver. J Clin Endocrinol Metab. 1990;71:1561-6
  12. Fonseca V, Epstein O, Gill DS, et al. Hyperparathyroidsm and low serum osteocalsin despite vitamin D replacement in primary biliary cirrhosis. J. Clin Endocrinol Metab. 1987;64:873-7
  13. Hodgson SF, Dickson ER, Wahner HW, et al. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985;103:855-60
  14. Pietschmann P, Resch H. Decreased serum osteocalcin levels in patients with liver cirrhosis. Bone Miner. 1990;8:103-8 17. Kalef-Ezra JA, Merkouropoulos MH, Challa A, et al. Amount and composition of bone minerals in chronic liver disease. Dig Dis Sci 1996;41:1008-13
  15. Conte N, Cecchettin M, Menente P, et al. Calcitonin in hepatoma and cirhossis. Acta Endocrinologica 1984;106:109-11. 19.Attila G, Matyar S. Plazma enzimlerinin tanısal değerleri. Mersin Ün.Tıp Fak. Derg. 2002;1:73-82
  16. Magnusson P, Hager A, Larsson L. Serum osteocalcin and bone liver alkaline phosphatase isoforms in healthy childre